Literature DB >> 11756229

Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.

Ming H Wu1, Jei H Chang, Benjamin Y M Yung.   

Abstract

Nucleophosmin/B23 was rapidly up-regulated after UV irradiation as p53, PCNA and c-Jun. UV induction of nucleophosmin/B23 was evidently increased at 3 h post-irradiation, and reached a maximum at 12 h, and remained high for at least 24 h. Over-expression of nucleophosmin/B23 made cells more resistant to UV-induced cell growth inhibition and death as compared with control vector-transfected cells through three main observations: cell growth/death percentage determination; clonogenic survival assay; and flow cytometric analysis. Moreover, nucleophosmin/B23 over-expressed cells had a greater capacity to repair UV-damaged reporter plasmid, indicating a higher nucleotide excision repair (NER) activity. Furthermore, PCNA, an essential component for DNA repair machinery, was correlated with nucleophosmin/B23 expression. Both protein level and promoter activity of PCNA were higher in nucleophosmin/B23 over-expressed cells than in control vector-transfected cells. On the other hand, treatment of cells with nucleophosmin/B23 antisense oligonucleotides decreased nucleophosmin/B23 and PCNA proteins, and potentiated the UV-induced cell killing. The effect of PCNA up-regulation may be one of the reasons that nucleophosmin/B23 over-expression made cells resistant to UV-induced growth inhibition and cell-killing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756229     DOI: 10.1093/carcin/23.1.93

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  33 in total

Review 1.  Nucleophosmin and human cancer.

Authors:  Mi Jung Lim; Xin Wei Wang
Journal:  Cancer Detect Prev       Date:  2006-11-17

2.  Long-term evolution and functional diversification in the members of the nucleophosmin/nucleoplasmin family of nuclear chaperones.

Authors:  José M Eirín-López; Lindsay J Frehlick; Juan Ausió
Journal:  Genetics       Date:  2006-06-04       Impact factor: 4.562

3.  The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Authors:  Narasimharao Nalabothula; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

4.  Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

Authors:  Narasimharao Nalabothula; Devulapalli Chakravarty; Adam Pierce; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

5.  Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Authors:  Amit Kumar; Javier Redondo-Muñoz; Vicente Perez-García; Isabel Cortes; Monica Chagoyen; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

6.  Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Authors:  Natasha Malik-Soni; Lori Frappier
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

7.  Nucleophosmin sets a threshold for p53 response to UV radiation.

Authors:  Dony A Maiguel; Leslie Jones; Devulapalli Chakravarty; Chonglin Yang; France Carrier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

9.  Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation.

Authors:  Mikael S Lindström; Yanping Zhang
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

Review 10.  Inflammation and endothelial dysfunction during aging: role of NF-kappaB.

Authors:  Anna Csiszar; Mingyi Wang; Edward G Lakatta; Zoltan Ungvari
Journal:  J Appl Physiol (1985)       Date:  2008-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.